What should you know about stage 1 TNBC prognosis?

Stage 1 indicates an early diagnosis, generally involving a limited breast tumour with no cancer found in the assessed lymph nodes. TNBC lacks hormone receptors and HER2, so its treatment and follow-up discussions differ from some other breast cancers.

Pathology gives additional information, including grade and margins. If treatment is given before surgery, the amount of cancer remaining at surgery can help the team plan the next step. These details are more useful for an individual discussion than a stage label on its own.

Ask for your pathology report to be explained in plain language, including tumour size, grade, margins, lymph nodes and response to any treatment before surgery. Complete the agreed treatment plan and keep appointments even when you feel well.

Chemotherapy and, for selected patients, immunotherapy may be considered. A PARP inhibitor may be relevant when inherited or tumour gene findings meet the treatment criteria. Tell the team about new medicines, family history and symptoms that affect daily life.

Seek urgent medical advice for fever during treatment, sudden breathlessness, chest pain, confusion, severe allergic symptoms, or bleeding that does not settle. Call the team about a new breast or armpit swelling, persistent bone pain, unexplained weight change, or symptoms that are worsening rather than improving.

Which pathology features affect my outlook? What did my treatment response show? What follow-up schedule is appropriate for me? Which symptoms should I report immediately, and which can wait for my next appointment?